Recent studies indicate that the risk of thrombosis in hematologic patients may be similar or even higher than that found in patients with solid tumors. However, available information about pathogenesis and incidence of thrombosis in acute leukemia is limited. This review focuses on mechanisms underlying thrombosis in acute leukemia and discusses recent literature data
Thrombosis is rare in children but they are more common and severe in children with hematological ma...
Acute leukemia (ALL and AML) has an adverse effect hemostasis. Coagulopathy is a common comorbidity ...
Simple Summary The reported incidence of thrombotic events (TE) in non-promyelocytic acute myeloid l...
Recent studies indicate that the risk of thrombosis in hematologic patients may be similar or even h...
The association between thrombosis and cancer has been extensively studied since first pointed out b...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is t...
The management of thrombosis in patients with cancer is a clinical challenge. Although the prevalenc...
Although the occurrence of thrombosis in acute promyelocytic leukemia ( APL) has been reported durin...
Introduction: Thrombotic events (TE) appear to be more common in acute promyelocytic leukemia (APL) ...
Patients with haematological malignancy have a 28-fold increase risk to develop venous thromboemboli...
The rate of venous thromboembolism (VTE) in patients with acute leukemia or lymphomas is comparable ...
It is well known that solid cancers are associated with thromboembolic complications, but recent stu...
Thrombosis is rare in children but they are more common and severe in children with hematological ma...
Acute leukemia (ALL and AML) has an adverse effect hemostasis. Coagulopathy is a common comorbidity ...
Simple Summary The reported incidence of thrombotic events (TE) in non-promyelocytic acute myeloid l...
Recent studies indicate that the risk of thrombosis in hematologic patients may be similar or even h...
The association between thrombosis and cancer has been extensively studied since first pointed out b...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
In the last decades, evaluation of clinically relevant thrombotic complications in patients with acu...
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is t...
The management of thrombosis in patients with cancer is a clinical challenge. Although the prevalenc...
Although the occurrence of thrombosis in acute promyelocytic leukemia ( APL) has been reported durin...
Introduction: Thrombotic events (TE) appear to be more common in acute promyelocytic leukemia (APL) ...
Patients with haematological malignancy have a 28-fold increase risk to develop venous thromboemboli...
The rate of venous thromboembolism (VTE) in patients with acute leukemia or lymphomas is comparable ...
It is well known that solid cancers are associated with thromboembolic complications, but recent stu...
Thrombosis is rare in children but they are more common and severe in children with hematological ma...
Acute leukemia (ALL and AML) has an adverse effect hemostasis. Coagulopathy is a common comorbidity ...
Simple Summary The reported incidence of thrombotic events (TE) in non-promyelocytic acute myeloid l...